GNF SymAtlas + NCI-60 cancer cell lines, human (Su, 2004; Ross, 2000)
Gene Symbol | Gene ID | Gene Info |
---|---|---|
SOX13
|
ENSG00000143842.10 | SRY-box transcription factor 13 |
SOX12
|
ENSG00000177732.6 | SRY-box transcription factor 12 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
SOX12 | hg19_v2_chr20_+_306221_306239 | -0.30 | 5.7e-06 | Click! |
SOX13 | hg19_v2_chr1_+_204042723_204042784 | 0.17 | 1.3e-02 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr6_-_49712147 | 20.35 |
ENST00000433368.2
ENST00000354620.4 |
CRISP3
|
cysteine-rich secretory protein 3 |
chr2_+_90198535 | 19.39 |
ENST00000390276.2
|
IGKV1D-12
|
immunoglobulin kappa variable 1D-12 |
chr6_-_49712123 | 18.19 |
ENST00000263045.4
|
CRISP3
|
cysteine-rich secretory protein 3 |
chr2_+_90273679 | 17.52 |
ENST00000423080.2
|
IGKV3D-7
|
immunoglobulin kappa variable 3D-7 |
chr1_-_153363452 | 16.45 |
ENST00000368732.1
ENST00000368733.3 |
S100A8
|
S100 calcium binding protein A8 |
chr2_+_90211643 | 16.31 |
ENST00000390277.2
|
IGKV3D-11
|
immunoglobulin kappa variable 3D-11 |
chr6_-_32498046 | 15.06 |
ENST00000374975.3
|
HLA-DRB5
|
major histocompatibility complex, class II, DR beta 5 |
chr6_-_32557610 | 14.90 |
ENST00000360004.5
|
HLA-DRB1
|
major histocompatibility complex, class II, DR beta 1 |
chr2_-_89327228 | 14.69 |
ENST00000483158.1
|
IGKV3-11
|
immunoglobulin kappa variable 3-11 |
chr4_+_71337834 | 14.06 |
ENST00000304887.5
|
MUC7
|
mucin 7, secreted |
chr12_+_8995832 | 13.86 |
ENST00000541459.1
|
A2ML1
|
alpha-2-macroglobulin-like 1 |
chr2_+_90153696 | 13.63 |
ENST00000417279.2
|
IGKV3D-15
|
immunoglobulin kappa variable 3D-15 (gene/pseudogene) |
chr12_-_91505608 | 13.21 |
ENST00000266718.4
|
LUM
|
lumican |
chr12_-_11548496 | 13.01 |
ENST00000389362.4
ENST00000565533.1 ENST00000546254.1 |
PRB2
PRB1
|
proline-rich protein BstNI subfamily 2 proline-rich protein BstNI subfamily 1 |
chr12_-_11508520 | 12.86 |
ENST00000545626.1
ENST00000500254.2 |
PRB1
|
proline-rich protein BstNI subfamily 1 |
chr19_+_21264980 | 12.50 |
ENST00000596053.1
ENST00000597086.1 ENST00000596143.1 ENST00000596367.1 ENST00000601416.1 |
ZNF714
|
zinc finger protein 714 |
chr2_-_89385283 | 12.47 |
ENST00000390252.2
|
IGKV3-15
|
immunoglobulin kappa variable 3-15 |
chr18_+_72201829 | 12.22 |
ENST00000582365.1
|
CNDP1
|
carnosine dipeptidase 1 (metallopeptidase M20 family) |
chr11_-_59950622 | 11.94 |
ENST00000323961.3
ENST00000412309.2 |
MS4A6A
|
membrane-spanning 4-domains, subfamily A, member 6A |
chr4_+_71226468 | 11.94 |
ENST00000226460.4
|
SMR3A
|
submaxillary gland androgen regulated protein 3A |
chr17_+_56315936 | 11.71 |
ENST00000543544.1
|
LPO
|
lactoperoxidase |
chr18_+_74240610 | 11.43 |
ENST00000578092.1
ENST00000578613.1 ENST00000583578.1 |
LINC00908
|
long intergenic non-protein coding RNA 908 |
chr2_-_89278535 | 11.07 |
ENST00000390247.2
|
IGKV3-7
|
immunoglobulin kappa variable 3-7 (non-functional) |
chr17_+_56315787 | 10.85 |
ENST00000262290.4
ENST00000421678.2 |
LPO
|
lactoperoxidase |
chr3_-_112127981 | 10.75 |
ENST00000486726.2
|
RP11-231E6.1
|
RP11-231E6.1 |
chr1_+_152975488 | 10.55 |
ENST00000542696.1
|
SPRR3
|
small proline-rich protein 3 |
chr5_+_54320078 | 10.49 |
ENST00000231009.2
|
GZMK
|
granzyme K (granzyme 3; tryptase II) |
chr7_+_30960915 | 10.46 |
ENST00000441328.2
ENST00000409899.1 ENST00000409611.1 |
AQP1
|
aquaporin 1 (Colton blood group) |
chr19_-_21950362 | 10.40 |
ENST00000358296.6
|
ZNF100
|
zinc finger protein 100 |
chrY_+_15016013 | 10.25 |
ENST00000360160.4
ENST00000454054.1 |
DDX3Y
|
DEAD (Asp-Glu-Ala-Asp) box helicase 3, Y-linked |
chr19_-_23433144 | 10.23 |
ENST00000418100.1
ENST00000597537.1 ENST00000597037.1 |
ZNF724P
|
zinc finger protein 724, pseudogene |
chr2_+_207220463 | 9.59 |
ENST00000598562.1
|
AC017081.1
|
Uncharacterized protein |
chr12_-_11036844 | 9.37 |
ENST00000428168.2
|
PRH1
|
proline-rich protein HaeIII subfamily 1 |
chr2_-_201729284 | 9.35 |
ENST00000434813.2
|
CLK1
|
CDC-like kinase 1 |
chr16_+_58283814 | 9.13 |
ENST00000443128.2
ENST00000219299.4 |
CCDC113
|
coiled-coil domain containing 113 |
chr13_-_41706864 | 9.03 |
ENST00000379485.1
ENST00000499385.2 |
KBTBD6
|
kelch repeat and BTB (POZ) domain containing 6 |
chr11_+_128563652 | 8.95 |
ENST00000527786.2
|
FLI1
|
Fli-1 proto-oncogene, ETS transcription factor |
chr12_-_11463353 | 8.92 |
ENST00000279575.1
ENST00000535904.1 ENST00000445719.2 |
PRB4
|
proline-rich protein BstNI subfamily 4 |
chr2_-_201729393 | 8.77 |
ENST00000321356.4
|
CLK1
|
CDC-like kinase 1 |
chr2_-_157198860 | 8.34 |
ENST00000409572.1
|
NR4A2
|
nuclear receptor subfamily 4, group A, member 2 |
chr11_+_43380459 | 8.27 |
ENST00000299240.6
ENST00000039989.4 |
TTC17
|
tetratricopeptide repeat domain 17 |
chr12_+_9102632 | 8.18 |
ENST00000539240.1
|
KLRG1
|
killer cell lectin-like receptor subfamily G, member 1 |
chr12_+_11081828 | 8.00 |
ENST00000381847.3
ENST00000396400.3 |
PRH2
|
proline-rich protein HaeIII subfamily 2 |
chr10_+_70480963 | 7.95 |
ENST00000265872.6
ENST00000535016.1 ENST00000538031.1 ENST00000543719.1 ENST00000539539.1 ENST00000543225.1 ENST00000536012.1 ENST00000494903.2 |
CCAR1
|
cell division cycle and apoptosis regulator 1 |
chr11_+_128563948 | 7.78 |
ENST00000534087.2
|
FLI1
|
Fli-1 proto-oncogene, ETS transcription factor |
chr4_-_88450612 | 7.73 |
ENST00000418378.1
ENST00000282470.6 |
SPARCL1
|
SPARC-like 1 (hevin) |
chr19_-_4535233 | 7.57 |
ENST00000381848.3
ENST00000588887.1 ENST00000586133.1 |
PLIN5
|
perilipin 5 |
chr14_-_106330072 | 7.56 |
ENST00000488476.1
|
IGHJ5
|
immunoglobulin heavy joining 5 |
chr3_+_40518599 | 7.53 |
ENST00000314686.5
ENST00000447116.2 ENST00000429348.2 ENST00000456778.1 |
ZNF619
|
zinc finger protein 619 |
chr12_+_25205446 | 7.51 |
ENST00000557489.1
ENST00000354454.3 ENST00000536173.1 |
LRMP
|
lymphoid-restricted membrane protein |
chr11_-_59950519 | 7.48 |
ENST00000528851.1
|
MS4A6A
|
membrane-spanning 4-domains, subfamily A, member 6A |
chr2_-_100939195 | 7.47 |
ENST00000393437.3
|
LONRF2
|
LON peptidase N-terminal domain and ring finger 2 |
chr18_+_42260861 | 7.22 |
ENST00000282030.5
|
SETBP1
|
SET binding protein 1 |
chr11_+_60223312 | 7.16 |
ENST00000532491.1
ENST00000532073.1 ENST00000534668.1 ENST00000528313.1 ENST00000533306.1 |
MS4A1
|
membrane-spanning 4-domains, subfamily A, member 1 |
chr11_+_93479588 | 7.13 |
ENST00000526335.1
|
C11orf54
|
chromosome 11 open reading frame 54 |
chr7_+_20686946 | 7.09 |
ENST00000443026.2
ENST00000406935.1 |
ABCB5
|
ATP-binding cassette, sub-family B (MDR/TAP), member 5 |
chr6_+_32605195 | 7.02 |
ENST00000374949.2
|
HLA-DQA1
|
major histocompatibility complex, class II, DQ alpha 1 |
chr5_-_86534822 | 7.00 |
ENST00000445770.2
|
AC008394.1
|
Uncharacterized protein |
chr12_+_25205568 | 6.99 |
ENST00000548766.1
ENST00000556887.1 |
LRMP
|
lymphoid-restricted membrane protein |
chr4_+_70916119 | 6.95 |
ENST00000246896.3
ENST00000511674.1 |
HTN1
|
histatin 1 |
chr19_+_13858593 | 6.82 |
ENST00000221554.8
|
CCDC130
|
coiled-coil domain containing 130 |
chr12_-_10022735 | 6.80 |
ENST00000228438.2
|
CLEC2B
|
C-type lectin domain family 2, member B |
chr12_+_25205666 | 6.77 |
ENST00000547044.1
|
LRMP
|
lymphoid-restricted membrane protein |
chr6_-_27858570 | 6.75 |
ENST00000359303.2
|
HIST1H3J
|
histone cluster 1, H3j |
chr16_-_70239683 | 6.75 |
ENST00000601706.1
|
AC009060.1
|
Uncharacterized protein |
chr6_-_99873145 | 6.66 |
ENST00000369239.5
ENST00000438806.1 |
PNISR
|
PNN-interacting serine/arginine-rich protein |
chrX_+_107288197 | 6.64 |
ENST00000415430.3
|
VSIG1
|
V-set and immunoglobulin domain containing 1 |
chr12_-_11422630 | 6.56 |
ENST00000381842.3
ENST00000538488.1 |
PRB3
|
proline-rich protein BstNI subfamily 3 |
chr11_+_60223225 | 6.47 |
ENST00000524807.1
ENST00000345732.4 |
MS4A1
|
membrane-spanning 4-domains, subfamily A, member 1 |
chr18_-_44497308 | 6.44 |
ENST00000585916.1
ENST00000324794.7 ENST00000545673.1 |
PIAS2
|
protein inhibitor of activated STAT, 2 |
chr6_-_133055815 | 6.40 |
ENST00000509351.1
ENST00000417437.2 ENST00000414302.2 ENST00000423615.2 ENST00000427187.2 ENST00000275223.3 ENST00000519686.2 |
VNN3
|
vanin 3 |
chr7_+_111846741 | 6.36 |
ENST00000421043.1
ENST00000425229.1 ENST00000450657.1 |
ZNF277
|
zinc finger protein 277 |
chr11_-_85393886 | 6.31 |
ENST00000534224.1
|
CREBZF
|
CREB/ATF bZIP transcription factor |
chr9_-_98079965 | 6.31 |
ENST00000289081.3
|
FANCC
|
Fanconi anemia, complementation group C |
chr8_+_24151553 | 6.30 |
ENST00000265769.4
ENST00000540823.1 ENST00000397649.3 |
ADAM28
|
ADAM metallopeptidase domain 28 |
chr11_+_7110165 | 6.27 |
ENST00000306904.5
|
RBMXL2
|
RNA binding motif protein, X-linked-like 2 |
chrX_+_108780347 | 6.26 |
ENST00000372103.1
|
NXT2
|
nuclear transport factor 2-like export factor 2 |
chrX_+_107288239 | 6.21 |
ENST00000217957.5
|
VSIG1
|
V-set and immunoglobulin domain containing 1 |
chr11_+_57365150 | 6.17 |
ENST00000457869.1
ENST00000340687.6 ENST00000378323.4 ENST00000378324.2 ENST00000403558.1 |
SERPING1
|
serpin peptidase inhibitor, clade G (C1 inhibitor), member 1 |
chr4_+_102734967 | 6.16 |
ENST00000444316.2
|
BANK1
|
B-cell scaffold protein with ankyrin repeats 1 |
chr2_+_90121477 | 6.14 |
ENST00000483379.1
|
IGKV1D-17
|
immunoglobulin kappa variable 1D-17 |
chr19_+_35609380 | 6.12 |
ENST00000604621.1
|
FXYD3
|
FXYD domain containing ion transport regulator 3 |
chr5_-_147211226 | 5.99 |
ENST00000296695.5
|
SPINK1
|
serine peptidase inhibitor, Kazal type 1 |
chr2_+_90077680 | 5.81 |
ENST00000390270.2
|
IGKV3D-20
|
immunoglobulin kappa variable 3D-20 |
chr19_+_21324827 | 5.77 |
ENST00000600692.1
ENST00000599296.1 ENST00000594425.1 ENST00000311048.7 |
ZNF431
|
zinc finger protein 431 |
chr11_+_49050504 | 5.69 |
ENST00000332682.7
|
TRIM49B
|
tripartite motif containing 49B |
chr4_+_88754113 | 5.62 |
ENST00000560249.1
ENST00000540395.1 ENST00000511670.1 ENST00000361056.3 |
MEPE
|
matrix extracellular phosphoglycoprotein |
chr3_-_57678772 | 5.56 |
ENST00000311128.5
|
DENND6A
|
DENN/MADD domain containing 6A |
chr14_+_21423611 | 5.54 |
ENST00000304625.2
|
RNASE2
|
ribonuclease, RNase A family, 2 (liver, eosinophil-derived neurotoxin) |
chr11_+_5710919 | 5.53 |
ENST00000379965.3
ENST00000425490.1 |
TRIM22
|
tripartite motif containing 22 |
chr12_-_11422739 | 5.48 |
ENST00000279573.7
|
PRB3
|
proline-rich protein BstNI subfamily 3 |
chr12_-_10282836 | 5.43 |
ENST00000304084.8
ENST00000353231.5 ENST00000525605.1 |
CLEC7A
|
C-type lectin domain family 7, member A |
chr4_+_70894130 | 5.40 |
ENST00000526767.1
ENST00000530128.1 ENST00000381057.3 |
HTN3
|
histatin 3 |
chr2_-_208489707 | 5.39 |
ENST00000448007.2
ENST00000432416.1 ENST00000411432.1 |
METTL21A
|
methyltransferase like 21A |
chr8_+_27631903 | 5.36 |
ENST00000305188.8
|
ESCO2
|
establishment of sister chromatid cohesion N-acetyltransferase 2 |
chr11_-_8190534 | 5.35 |
ENST00000309737.6
ENST00000425599.2 ENST00000539720.1 ENST00000531450.1 ENST00000419822.2 ENST00000335425.7 ENST00000343202.4 |
RIC3
|
RIC3 acetylcholine receptor chaperone |
chr19_+_58790314 | 5.32 |
ENST00000196548.5
ENST00000608843.1 |
ZNF8
ZNF8
|
Zinc finger protein 8 zinc finger protein 8 |
chr1_-_158656488 | 5.21 |
ENST00000368147.4
|
SPTA1
|
spectrin, alpha, erythrocytic 1 (elliptocytosis 2) |
chr2_-_110962544 | 5.15 |
ENST00000355301.4
ENST00000445609.2 ENST00000417665.1 ENST00000418527.1 ENST00000316534.4 ENST00000393272.3 |
NPHP1
|
nephronophthisis 1 (juvenile) |
chr19_+_42212526 | 5.07 |
ENST00000598976.1
ENST00000435837.2 ENST00000221992.6 ENST00000405816.1 |
CEA
CEACAM5
|
Uncharacterized protein carcinoembryonic antigen-related cell adhesion molecule 5 |
chr1_-_153013588 | 5.06 |
ENST00000360379.3
|
SPRR2D
|
small proline-rich protein 2D |
chr4_+_71063641 | 5.05 |
ENST00000514097.1
|
ODAM
|
odontogenic, ameloblast asssociated |
chr1_-_26324534 | 5.01 |
ENST00000374284.1
ENST00000441420.1 ENST00000374282.3 |
PAFAH2
|
platelet-activating factor acetylhydrolase 2, 40kDa |
chr7_-_38305279 | 4.99 |
ENST00000443402.2
|
TRGC1
|
T cell receptor gamma constant 1 |
chr1_+_66797687 | 4.94 |
ENST00000371045.5
ENST00000531025.1 ENST00000526197.1 |
PDE4B
|
phosphodiesterase 4B, cAMP-specific |
chr5_+_94890778 | 4.94 |
ENST00000380009.4
|
ARSK
|
arylsulfatase family, member K |
chr4_+_128554081 | 4.77 |
ENST00000335251.6
ENST00000296461.5 |
INTU
|
inturned planar cell polarity protein |
chr8_-_27941380 | 4.77 |
ENST00000413272.2
ENST00000341513.6 |
NUGGC
|
nuclear GTPase, germinal center associated |
chr3_-_18466026 | 4.71 |
ENST00000417717.2
|
SATB1
|
SATB homeobox 1 |
chr4_+_88754069 | 4.71 |
ENST00000395102.4
ENST00000497649.2 |
MEPE
|
matrix extracellular phosphoglycoprotein |
chr2_+_103035102 | 4.60 |
ENST00000264260.2
|
IL18RAP
|
interleukin 18 receptor accessory protein |
chr19_+_42212501 | 4.55 |
ENST00000398599.4
|
CEACAM5
|
carcinoembryonic antigen-related cell adhesion molecule 5 |
chr16_+_85942594 | 4.53 |
ENST00000566369.1
|
IRF8
|
interferon regulatory factor 8 |
chr11_+_55029628 | 4.51 |
ENST00000417545.2
|
TRIM48
|
tripartite motif containing 48 |
chr1_+_162039558 | 4.51 |
ENST00000530878.1
ENST00000361897.5 |
NOS1AP
|
nitric oxide synthase 1 (neuronal) adaptor protein |
chr1_-_179846928 | 4.49 |
ENST00000367612.3
ENST00000609928.1 |
TOR1AIP2
|
torsin A interacting protein 2 |
chr11_-_89224638 | 4.48 |
ENST00000535633.1
ENST00000263317.4 |
NOX4
|
NADPH oxidase 4 |
chr6_+_150920999 | 4.47 |
ENST00000367328.1
ENST00000367326.1 |
PLEKHG1
|
pleckstrin homology domain containing, family G (with RhoGef domain) member 1 |
chr2_+_169923504 | 4.39 |
ENST00000357546.2
|
DHRS9
|
dehydrogenase/reductase (SDR family) member 9 |
chr14_+_74111578 | 4.29 |
ENST00000554113.1
ENST00000555631.2 ENST00000553645.2 ENST00000311089.3 ENST00000555919.3 ENST00000554339.1 ENST00000554871.1 |
DNAL1
|
dynein, axonemal, light chain 1 |
chr1_-_244006528 | 4.28 |
ENST00000336199.5
ENST00000263826.5 |
AKT3
|
v-akt murine thymoma viral oncogene homolog 3 |
chr1_+_153388993 | 4.26 |
ENST00000368729.4
|
S100A7A
|
S100 calcium binding protein A7A |
chrX_+_108779870 | 4.25 |
ENST00000372107.1
|
NXT2
|
nuclear transport factor 2-like export factor 2 |
chr19_+_13842559 | 4.17 |
ENST00000586600.1
|
CCDC130
|
coiled-coil domain containing 130 |
chr6_-_52705641 | 4.16 |
ENST00000370989.2
|
GSTA5
|
glutathione S-transferase alpha 5 |
chr10_+_76871353 | 4.14 |
ENST00000542569.1
|
SAMD8
|
sterile alpha motif domain containing 8 |
chr12_-_11002063 | 4.14 |
ENST00000544994.1
ENST00000228811.4 ENST00000540107.1 |
PRR4
|
proline rich 4 (lacrimal) |
chr4_-_57547454 | 4.12 |
ENST00000556376.2
|
HOPX
|
HOP homeobox |
chr21_+_43619796 | 4.10 |
ENST00000398457.2
|
ABCG1
|
ATP-binding cassette, sub-family G (WHITE), member 1 |
chr5_-_147211190 | 4.09 |
ENST00000510027.2
|
SPINK1
|
serine peptidase inhibitor, Kazal type 1 |
chr4_+_70861647 | 4.09 |
ENST00000246895.4
ENST00000381060.2 |
STATH
|
statherin |
chr12_+_32655048 | 4.05 |
ENST00000427716.2
ENST00000266482.3 |
FGD4
|
FYVE, RhoGEF and PH domain containing 4 |
chr14_+_37126765 | 4.03 |
ENST00000402703.2
|
PAX9
|
paired box 9 |
chr11_+_92085262 | 4.02 |
ENST00000298047.6
ENST00000409404.2 ENST00000541502.1 |
FAT3
|
FAT atypical cadherin 3 |
chr16_-_18462221 | 3.97 |
ENST00000528301.1
|
RP11-1212A22.4
|
LOC339047 protein; Nuclear pore complex-interacting protein family member A3; Nuclear pore complex-interacting protein family member A5; Protein PKD1P1 |
chr2_+_89923550 | 3.96 |
ENST00000509129.1
|
IGKV1D-37
|
immunoglobulin kappa variable 1D-37 (non-functional) |
chr8_+_28747884 | 3.95 |
ENST00000287701.10
ENST00000444075.1 ENST00000403668.2 ENST00000519662.1 ENST00000558662.1 ENST00000523613.1 ENST00000560599.1 ENST00000397358.3 |
HMBOX1
|
homeobox containing 1 |
chr11_-_59950486 | 3.93 |
ENST00000426738.2
ENST00000533023.1 ENST00000420732.2 |
MS4A6A
|
membrane-spanning 4-domains, subfamily A, member 6A |
chr3_-_101232019 | 3.92 |
ENST00000394095.2
ENST00000394091.1 ENST00000394094.2 ENST00000358203.3 ENST00000348610.3 ENST00000314261.7 |
SENP7
|
SUMO1/sentrin specific peptidase 7 |
chr7_-_150329421 | 3.91 |
ENST00000493969.1
ENST00000328902.5 |
GIMAP6
|
GTPase, IMAP family member 6 |
chr4_+_2819883 | 3.89 |
ENST00000511747.1
ENST00000503393.2 |
SH3BP2
|
SH3-domain binding protein 2 |
chr17_-_73663168 | 3.88 |
ENST00000578201.1
ENST00000423245.2 |
RECQL5
|
RecQ protein-like 5 |
chr1_+_13910194 | 3.87 |
ENST00000376057.4
ENST00000510906.1 |
PDPN
|
podoplanin |
chr8_+_117950422 | 3.83 |
ENST00000378279.3
|
AARD
|
alanine and arginine rich domain containing protein |
chr14_+_50291993 | 3.82 |
ENST00000595378.1
|
AL627171.2
|
HCG1786899; PRO2610; Uncharacterized protein |
chr14_-_64761078 | 3.79 |
ENST00000341099.4
ENST00000556275.1 ENST00000542956.1 ENST00000353772.3 ENST00000357782.2 ENST00000267525.6 |
ESR2
|
estrogen receptor 2 (ER beta) |
chr2_-_89597542 | 3.78 |
ENST00000465170.1
|
IGKV1-37
|
immunoglobulin kappa variable 1-37 (non-functional) |
chr6_-_41254403 | 3.75 |
ENST00000589614.1
ENST00000334475.6 ENST00000591620.1 ENST00000244709.4 |
TREM1
|
triggering receptor expressed on myeloid cells 1 |
chr4_+_71248795 | 3.72 |
ENST00000304915.3
|
SMR3B
|
submaxillary gland androgen regulated protein 3B |
chr4_+_74275057 | 3.67 |
ENST00000511370.1
|
ALB
|
albumin |
chr11_-_89540388 | 3.67 |
ENST00000532501.2
|
TRIM49
|
tripartite motif containing 49 |
chr4_-_121843985 | 3.63 |
ENST00000264808.3
ENST00000428209.2 ENST00000515109.1 ENST00000394435.2 |
PRDM5
|
PR domain containing 5 |
chr4_-_174451370 | 3.63 |
ENST00000359562.4
|
HAND2
|
heart and neural crest derivatives expressed 2 |
chr9_-_21351377 | 3.61 |
ENST00000380210.1
|
IFNA6
|
interferon, alpha 6 |
chr8_+_22462532 | 3.59 |
ENST00000389279.3
|
CCAR2
|
cell cycle and apoptosis regulator 2 |
chr6_-_44281043 | 3.56 |
ENST00000244571.4
|
AARS2
|
alanyl-tRNA synthetase 2, mitochondrial |
chr17_-_73663245 | 3.55 |
ENST00000584999.1
ENST00000317905.5 ENST00000420326.2 ENST00000340830.5 |
RECQL5
|
RecQ protein-like 5 |
chr1_+_215747118 | 3.54 |
ENST00000448333.1
|
KCTD3
|
potassium channel tetramerization domain containing 3 |
chr1_+_153003671 | 3.50 |
ENST00000307098.4
|
SPRR1B
|
small proline-rich protein 1B |
chr19_+_21106081 | 3.48 |
ENST00000300540.3
ENST00000595854.1 ENST00000601284.1 ENST00000328178.8 ENST00000599885.1 ENST00000596476.1 ENST00000345030.6 |
ZNF85
|
zinc finger protein 85 |
chr6_+_26204825 | 3.48 |
ENST00000360441.4
|
HIST1H4E
|
histone cluster 1, H4e |
chr1_+_21877753 | 3.47 |
ENST00000374832.1
|
ALPL
|
alkaline phosphatase, liver/bone/kidney |
chr19_-_14785622 | 3.47 |
ENST00000443157.2
|
EMR3
|
egf-like module containing, mucin-like, hormone receptor-like 3 |
chr4_+_165675269 | 3.45 |
ENST00000507311.1
|
RP11-294O2.2
|
RP11-294O2.2 |
chr8_-_82024290 | 3.44 |
ENST00000220597.4
|
PAG1
|
phosphoprotein associated with glycosphingolipid microdomains 1 |
chr16_-_15187865 | 3.43 |
ENST00000327307.7
|
RRN3
|
RRN3 RNA polymerase I transcription factor homolog (S. cerevisiae) |
chr19_-_14952689 | 3.40 |
ENST00000248058.1
|
OR7A10
|
olfactory receptor, family 7, subfamily A, member 10 |
chr19_+_55105085 | 3.40 |
ENST00000251372.3
ENST00000453777.1 |
LILRA1
|
leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 1 |
chr16_+_48278178 | 3.39 |
ENST00000285737.4
ENST00000535754.1 |
LONP2
|
lon peptidase 2, peroxisomal |
chr16_+_67381289 | 3.37 |
ENST00000435835.3
|
LRRC36
|
leucine rich repeat containing 36 |
chr12_+_101988774 | 3.35 |
ENST00000545503.2
ENST00000536007.1 ENST00000541119.1 ENST00000361466.2 ENST00000551300.1 ENST00000550270.1 |
MYBPC1
|
myosin binding protein C, slow type |
chr15_+_85923797 | 3.33 |
ENST00000559362.1
|
AKAP13
|
A kinase (PRKA) anchor protein 13 |
chr12_-_15114603 | 3.32 |
ENST00000228945.4
|
ARHGDIB
|
Rho GDP dissociation inhibitor (GDI) beta |
chr6_+_106534192 | 3.30 |
ENST00000369091.2
ENST00000369096.4 |
PRDM1
|
PR domain containing 1, with ZNF domain |
chr6_+_20534672 | 3.29 |
ENST00000274695.4
ENST00000378624.4 |
CDKAL1
|
CDK5 regulatory subunit associated protein 1-like 1 |
chr14_-_106330458 | 3.29 |
ENST00000461719.1
|
IGHJ4
|
immunoglobulin heavy joining 4 |
chr3_+_171561127 | 3.26 |
ENST00000334567.5
ENST00000450693.1 |
TMEM212
|
transmembrane protein 212 |
chr2_-_89545079 | 3.22 |
ENST00000468494.1
|
IGKV2-30
|
immunoglobulin kappa variable 2-30 |
chr2_+_132479948 | 3.19 |
ENST00000355171.4
|
C2orf27A
|
chromosome 2 open reading frame 27A |
chr16_-_20362147 | 3.19 |
ENST00000396142.2
|
UMOD
|
uromodulin |
chr5_+_35856951 | 3.18 |
ENST00000303115.3
ENST00000343305.4 ENST00000506850.1 ENST00000511982.1 |
IL7R
|
interleukin 7 receptor |
chr15_-_45670924 | 3.15 |
ENST00000396659.3
|
GATM
|
glycine amidinotransferase (L-arginine:glycine amidinotransferase) |
chr10_-_61720640 | 3.14 |
ENST00000521074.1
ENST00000444900.1 |
C10orf40
|
chromosome 10 open reading frame 40 |
chr1_-_153029980 | 3.14 |
ENST00000392653.2
|
SPRR2A
|
small proline-rich protein 2A |
chr19_+_55141948 | 3.13 |
ENST00000396332.4
ENST00000427581.2 |
LILRB1
|
leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 1 |
chr14_-_107083690 | 3.11 |
ENST00000455737.1
ENST00000390629.2 |
IGHV4-59
|
immunoglobulin heavy variable 4-59 |
chr1_-_203151933 | 3.11 |
ENST00000404436.2
|
CHI3L1
|
chitinase 3-like 1 (cartilage glycoprotein-39) |
chr2_+_33661382 | 3.11 |
ENST00000402538.3
|
RASGRP3
|
RAS guanyl releasing protein 3 (calcium and DAG-regulated) |
chr7_-_82792215 | 3.09 |
ENST00000333891.9
ENST00000423517.2 |
PCLO
|
piccolo presynaptic cytomatrix protein |
chr19_+_44556158 | 3.09 |
ENST00000434772.3
ENST00000585552.1 |
ZNF223
|
zinc finger protein 223 |
chr19_+_21579908 | 3.07 |
ENST00000596302.1
ENST00000392288.2 ENST00000594390.1 ENST00000355504.4 |
ZNF493
|
zinc finger protein 493 |
chr9_-_115818951 | 3.05 |
ENST00000553380.1
ENST00000374227.3 |
ZFP37
|
ZFP37 zinc finger protein |
chr20_-_1638360 | 2.94 |
ENST00000216927.4
ENST00000344103.4 |
SIRPG
|
signal-regulatory protein gamma |
chr2_+_102927962 | 2.94 |
ENST00000233954.1
ENST00000393393.3 ENST00000410040.1 |
IL1RL1
IL18R1
|
interleukin 1 receptor-like 1 interleukin 18 receptor 1 |
chr3_+_44690211 | 2.93 |
ENST00000396056.2
ENST00000432115.2 ENST00000415571.2 ENST00000399560.2 ENST00000296092.3 ENST00000542250.1 ENST00000453164.1 |
ZNF35
|
zinc finger protein 35 |
chr11_+_73661364 | 2.92 |
ENST00000339764.1
|
DNAJB13
|
DnaJ (Hsp40) homolog, subfamily B, member 13 |
chr6_+_126070726 | 2.91 |
ENST00000368364.3
|
HEY2
|
hes-related family bHLH transcription factor with YRPW motif 2 |
chr19_+_4402659 | 2.90 |
ENST00000301280.5
ENST00000585854.1 |
CHAF1A
|
chromatin assembly factor 1, subunit A (p150) |
chr8_+_24151620 | 2.89 |
ENST00000437154.2
|
ADAM28
|
ADAM metallopeptidase domain 28 |
chr18_+_74240756 | 2.85 |
ENST00000584910.1
ENST00000582452.1 |
LINC00908
|
long intergenic non-protein coding RNA 908 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.6 | 10.9 | GO:0035378 | carbon dioxide transmembrane transport(GO:0035378) |
3.0 | 14.9 | GO:0002399 | MHC class II protein complex assembly(GO:0002399) |
2.8 | 8.3 | GO:0021538 | epithalamus development(GO:0021538) habenula development(GO:0021986) |
2.5 | 7.6 | GO:0035359 | negative regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035359) |
2.5 | 7.4 | GO:1990414 | replication-born double-strand break repair via sister chromatid exchange(GO:1990414) |
2.4 | 16.5 | GO:0032119 | sequestering of zinc ion(GO:0032119) |
2.2 | 15.1 | GO:0010749 | regulation of nitric oxide mediated signal transduction(GO:0010749) |
1.9 | 5.7 | GO:1900169 | regulation of glucocorticoid mediated signaling pathway(GO:1900169) |
1.9 | 13.2 | GO:0032914 | positive regulation of transforming growth factor beta1 production(GO:0032914) |
1.8 | 7.1 | GO:0048749 | compound eye development(GO:0048749) |
1.7 | 5.2 | GO:1903348 | positive regulation of bicellular tight junction assembly(GO:1903348) |
1.5 | 4.5 | GO:1902161 | positive regulation of cyclic nucleotide-gated ion channel activity(GO:1902161) |
1.5 | 5.8 | GO:0035548 | gamma-delta T cell activation involved in immune response(GO:0002290) negative regulation of interferon-beta secretion(GO:0035548) regulation of gamma-delta T cell activation involved in immune response(GO:2001191) positive regulation of gamma-delta T cell activation involved in immune response(GO:2001193) |
1.4 | 4.3 | GO:0052331 | hemolysis by symbiont of host erythrocytes(GO:0019836) hemolysis in other organism(GO:0044179) hemolysis in other organism involved in symbiotic interaction(GO:0052331) |
1.4 | 4.1 | GO:0009726 | detection of endogenous stimulus(GO:0009726) |
1.4 | 4.1 | GO:0070340 | detection of bacterial lipoprotein(GO:0042494) detection of triacyl bacterial lipopeptide(GO:0042495) detection of bacterial lipopeptide(GO:0070340) |
1.3 | 3.9 | GO:0071301 | cellular response to vitamin B1(GO:0071301) response to formaldehyde(GO:1904404) |
1.3 | 3.9 | GO:1990764 | regulation of myofibroblast contraction(GO:1904328) myofibroblast contraction(GO:1990764) |
1.3 | 3.8 | GO:0030324 | respiratory tube development(GO:0030323) lung development(GO:0030324) |
1.3 | 5.0 | GO:0060054 | positive regulation of epithelial cell proliferation involved in wound healing(GO:0060054) |
1.2 | 3.6 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
1.2 | 3.5 | GO:0071529 | cementum mineralization(GO:0071529) |
1.1 | 11.3 | GO:0015939 | pantothenate metabolic process(GO:0015939) |
1.0 | 2.1 | GO:0002581 | negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002581) |
1.0 | 4.0 | GO:0044240 | multicellular organism lipid catabolic process(GO:0044240) |
1.0 | 5.0 | GO:0014055 | acetylcholine secretion, neurotransmission(GO:0014055) regulation of acetylcholine secretion, neurotransmission(GO:0014056) |
1.0 | 2.9 | GO:0010621 | negative regulation of transcription by transcription factor localization(GO:0010621) |
0.9 | 2.7 | GO:0072137 | condensed mesenchymal cell proliferation(GO:0072137) |
0.8 | 3.3 | GO:0071461 | cellular response to redox state(GO:0071461) |
0.8 | 2.5 | GO:0044210 | 'de novo' CTP biosynthetic process(GO:0044210) |
0.8 | 4.0 | GO:0072233 | thick ascending limb development(GO:0072023) metanephric thick ascending limb development(GO:0072233) |
0.8 | 6.9 | GO:0001865 | NK T cell differentiation(GO:0001865) |
0.8 | 16.7 | GO:0035855 | megakaryocyte development(GO:0035855) |
0.8 | 2.3 | GO:0002541 | activation of plasma proteins involved in acute inflammatory response(GO:0002541) |
0.7 | 2.2 | GO:0060474 | positive regulation of sperm motility involved in capacitation(GO:0060474) |
0.7 | 8.7 | GO:1901898 | negative regulation of relaxation of cardiac muscle(GO:1901898) |
0.7 | 3.6 | GO:0061032 | cardiac right ventricle formation(GO:0003219) visceral serous pericardium development(GO:0061032) |
0.7 | 2.2 | GO:0033326 | cerebrospinal fluid secretion(GO:0033326) |
0.7 | 14.1 | GO:0030277 | maintenance of gastrointestinal epithelium(GO:0030277) |
0.7 | 2.8 | GO:0021997 | response to chlorate(GO:0010157) neural plate axis specification(GO:0021997) |
0.7 | 2.7 | GO:0019470 | 4-hydroxyproline catabolic process(GO:0019470) |
0.7 | 2.0 | GO:0050760 | negative regulation of thymidylate synthase biosynthetic process(GO:0050760) |
0.7 | 6.6 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
0.6 | 1.9 | GO:0071409 | cellular response to cycloheximide(GO:0071409) |
0.6 | 3.8 | GO:0070945 | neutrophil mediated killing of gram-negative bacterium(GO:0070945) |
0.6 | 3.1 | GO:1904845 | response to L-glutamine(GO:1904844) cellular response to L-glutamine(GO:1904845) |
0.6 | 6.2 | GO:1900165 | negative regulation of interleukin-6 secretion(GO:1900165) |
0.6 | 1.8 | GO:0090219 | negative regulation of lipid kinase activity(GO:0090219) |
0.6 | 14.4 | GO:0030502 | negative regulation of bone mineralization(GO:0030502) |
0.6 | 2.2 | GO:0001970 | positive regulation of activation of membrane attack complex(GO:0001970) |
0.6 | 2.2 | GO:0015808 | L-alanine transport(GO:0015808) |
0.5 | 14.5 | GO:0001580 | detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
0.5 | 2.6 | GO:0071477 | hypotonic salinity response(GO:0042539) cellular hypotonic salinity response(GO:0071477) |
0.5 | 2.6 | GO:1902714 | negative regulation of interferon-gamma secretion(GO:1902714) |
0.5 | 6.2 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
0.5 | 5.6 | GO:2000049 | positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
0.5 | 3.4 | GO:0001180 | transcription initiation from RNA polymerase I promoter for nuclear large rRNA transcript(GO:0001180) |
0.5 | 26.4 | GO:0044364 | killing of cells of other organism(GO:0031640) disruption of cells of other organism(GO:0044364) |
0.5 | 1.9 | GO:0036269 | swimming behavior(GO:0036269) |
0.5 | 1.4 | GO:0035603 | fibroblast growth factor receptor signaling pathway involved in negative regulation of apoptotic process in bone marrow(GO:0035602) fibroblast growth factor receptor signaling pathway involved in hemopoiesis(GO:0035603) fibroblast growth factor receptor signaling pathway involved in positive regulation of cell proliferation in bone marrow(GO:0035604) fibroblast growth factor receptor signaling pathway involved in mammary gland specification(GO:0060595) mammary gland bud formation(GO:0060615) branch elongation involved in salivary gland morphogenesis(GO:0060667) mesenchymal cell differentiation involved in lung development(GO:0060915) |
0.5 | 1.4 | GO:0048539 | bone marrow development(GO:0048539) |
0.5 | 1.8 | GO:0070131 | positive regulation of mitochondrial translation(GO:0070131) |
0.4 | 73.7 | GO:0002377 | immunoglobulin production(GO:0002377) |
0.4 | 1.3 | GO:0019853 | L-ascorbic acid biosynthetic process(GO:0019853) negative regulation of DNA catabolic process(GO:1903625) regulation of aminoacyl-tRNA ligase activity(GO:1903630) |
0.4 | 10.0 | GO:0042832 | defense response to protozoan(GO:0042832) |
0.4 | 1.3 | GO:0035948 | positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter(GO:0035948) |
0.4 | 1.2 | GO:0006711 | estrogen catabolic process(GO:0006711) |
0.4 | 2.4 | GO:2000324 | positive regulation of glucocorticoid receptor signaling pathway(GO:2000324) |
0.4 | 1.6 | GO:0043570 | maintenance of DNA repeat elements(GO:0043570) |
0.4 | 52.4 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
0.4 | 1.2 | GO:0046013 | regulation of T cell homeostatic proliferation(GO:0046013) |
0.4 | 1.5 | GO:0042320 | regulation of circadian sleep/wake cycle, REM sleep(GO:0042320) |
0.4 | 6.4 | GO:0060766 | negative regulation of androgen receptor signaling pathway(GO:0060766) |
0.4 | 5.3 | GO:0071688 | striated muscle myosin thick filament assembly(GO:0071688) |
0.4 | 2.2 | GO:0099515 | vesicle transport along actin filament(GO:0030050) actin filament-based transport(GO:0099515) |
0.4 | 2.9 | GO:0035092 | sperm chromatin condensation(GO:0035092) |
0.4 | 1.1 | GO:0002314 | germinal center B cell differentiation(GO:0002314) |
0.4 | 2.2 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
0.4 | 4.3 | GO:0036158 | outer dynein arm assembly(GO:0036158) |
0.4 | 2.1 | GO:0044800 | fusion of virus membrane with host plasma membrane(GO:0019064) membrane fusion involved in viral entry into host cell(GO:0039663) multi-organism membrane fusion(GO:0044800) |
0.3 | 4.5 | GO:0090435 | protein localization to nuclear envelope(GO:0090435) |
0.3 | 0.7 | GO:0002740 | negative regulation of cytokine secretion involved in immune response(GO:0002740) |
0.3 | 4.5 | GO:0010668 | ectodermal cell differentiation(GO:0010668) |
0.3 | 1.3 | GO:1900736 | regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900736) |
0.3 | 1.3 | GO:0060133 | somatotropin secreting cell development(GO:0060133) |
0.3 | 1.0 | GO:0010737 | protein kinase A signaling(GO:0010737) |
0.3 | 2.0 | GO:0055059 | asymmetric neuroblast division(GO:0055059) |
0.3 | 1.3 | GO:0071492 | cellular response to UV-A(GO:0071492) |
0.3 | 1.6 | GO:1900020 | regulation of protein kinase C activity(GO:1900019) positive regulation of protein kinase C activity(GO:1900020) |
0.3 | 8.0 | GO:0010832 | negative regulation of myotube differentiation(GO:0010832) |
0.3 | 4.7 | GO:0043374 | CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
0.3 | 2.2 | GO:0010819 | regulation of T cell chemotaxis(GO:0010819) positive regulation of T cell chemotaxis(GO:0010820) |
0.3 | 2.5 | GO:0003406 | retinal pigment epithelium development(GO:0003406) |
0.3 | 0.9 | GO:0036150 | phosphatidylserine acyl-chain remodeling(GO:0036150) |
0.3 | 1.2 | GO:0006627 | protein processing involved in protein targeting to mitochondrion(GO:0006627) |
0.3 | 1.2 | GO:0017121 | phospholipid scrambling(GO:0017121) |
0.3 | 18.6 | GO:0018149 | peptide cross-linking(GO:0018149) |
0.3 | 2.4 | GO:0070995 | NADPH oxidation(GO:0070995) |
0.3 | 3.3 | GO:0042904 | 9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
0.3 | 3.3 | GO:0098789 | pre-mRNA cleavage required for polyadenylation(GO:0098789) |
0.3 | 1.8 | GO:0009744 | response to sucrose(GO:0009744) response to disaccharide(GO:0034285) |
0.3 | 3.2 | GO:0006600 | creatine metabolic process(GO:0006600) |
0.3 | 3.1 | GO:0006032 | chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
0.3 | 0.8 | GO:0010430 | fatty acid omega-oxidation(GO:0010430) |
0.3 | 3.6 | GO:0043653 | mitochondrial fragmentation involved in apoptotic process(GO:0043653) |
0.3 | 4.1 | GO:1905038 | regulation of sphingolipid biosynthetic process(GO:0090153) regulation of membrane lipid metabolic process(GO:1905038) regulation of ceramide biosynthetic process(GO:2000303) |
0.3 | 19.7 | GO:0042100 | B cell proliferation(GO:0042100) |
0.3 | 1.6 | GO:0033625 | positive regulation of integrin activation(GO:0033625) protein secretion by platelet(GO:0070560) |
0.3 | 1.4 | GO:0021759 | globus pallidus development(GO:0021759) |
0.3 | 0.8 | GO:0043324 | eye pigment biosynthetic process(GO:0006726) eye pigment metabolic process(GO:0042441) pigment metabolic process involved in developmental pigmentation(GO:0043324) pigment metabolic process involved in pigmentation(GO:0043474) |
0.3 | 3.4 | GO:0031998 | regulation of fatty acid beta-oxidation(GO:0031998) |
0.3 | 2.1 | GO:0001767 | establishment of lymphocyte polarity(GO:0001767) |
0.3 | 2.8 | GO:1902172 | keratinocyte apoptotic process(GO:0097283) regulation of keratinocyte apoptotic process(GO:1902172) |
0.3 | 1.0 | GO:0072675 | multinuclear osteoclast differentiation(GO:0072674) osteoclast fusion(GO:0072675) |
0.3 | 1.5 | GO:1904381 | Golgi apparatus mannose trimming(GO:1904381) |
0.3 | 4.8 | GO:0021513 | spinal cord dorsal/ventral patterning(GO:0021513) |
0.2 | 2.9 | GO:0035655 | interleukin-18-mediated signaling pathway(GO:0035655) cellular response to interleukin-18(GO:0071351) |
0.2 | 3.3 | GO:0010804 | negative regulation of tumor necrosis factor-mediated signaling pathway(GO:0010804) |
0.2 | 22.1 | GO:0031294 | lymphocyte costimulation(GO:0031294) T cell costimulation(GO:0031295) |
0.2 | 2.3 | GO:0050942 | positive regulation of pigment cell differentiation(GO:0050942) |
0.2 | 2.5 | GO:0014809 | regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion(GO:0014809) |
0.2 | 3.3 | GO:0060213 | regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060211) positive regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060213) |
0.2 | 1.6 | GO:0055096 | lipoprotein particle mediated signaling(GO:0055095) low-density lipoprotein particle mediated signaling(GO:0055096) |
0.2 | 1.1 | GO:2000382 | positive regulation of mesoderm development(GO:2000382) |
0.2 | 4.1 | GO:0001829 | trophectodermal cell differentiation(GO:0001829) |
0.2 | 5.4 | GO:0071168 | protein localization to chromatin(GO:0071168) |
0.2 | 0.9 | GO:0051029 | rRNA transport(GO:0051029) |
0.2 | 1.5 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
0.2 | 3.8 | GO:1900115 | extracellular regulation of signal transduction(GO:1900115) extracellular negative regulation of signal transduction(GO:1900116) |
0.2 | 0.8 | GO:0033313 | meiotic cell cycle checkpoint(GO:0033313) |
0.2 | 7.5 | GO:0034219 | carbohydrate transmembrane transport(GO:0034219) |
0.2 | 7.1 | GO:0050667 | homocysteine metabolic process(GO:0050667) |
0.2 | 0.4 | GO:0032431 | activation of phospholipase A2 activity(GO:0032431) |
0.2 | 1.6 | GO:0006452 | translational frameshifting(GO:0006452) positive regulation of translational termination(GO:0045905) |
0.2 | 0.8 | GO:0035234 | ectopic germ cell programmed cell death(GO:0035234) |
0.2 | 4.4 | GO:0019373 | epoxygenase P450 pathway(GO:0019373) |
0.2 | 1.2 | GO:1903244 | positive regulation of cardiac muscle adaptation(GO:0010615) positive regulation of cardiac muscle hypertrophy in response to stress(GO:1903244) |
0.2 | 5.5 | GO:2000772 | regulation of cellular senescence(GO:2000772) |
0.2 | 2.1 | GO:0045008 | depyrimidination(GO:0045008) |
0.2 | 4.1 | GO:0097150 | neuronal stem cell population maintenance(GO:0097150) |
0.2 | 0.2 | GO:0036215 | response to stem cell factor(GO:0036215) cellular response to stem cell factor stimulus(GO:0036216) Kit signaling pathway(GO:0038109) |
0.2 | 2.1 | GO:0070307 | lens fiber cell development(GO:0070307) |
0.2 | 0.7 | GO:0002415 | immunoglobulin transcytosis in epithelial cells mediated by polymeric immunoglobulin receptor(GO:0002415) |
0.2 | 1.7 | GO:0042940 | D-amino acid transport(GO:0042940) |
0.2 | 1.7 | GO:0042737 | drug catabolic process(GO:0042737) |
0.2 | 10.2 | GO:0006968 | cellular defense response(GO:0006968) |
0.2 | 4.3 | GO:0048873 | homeostasis of number of cells within a tissue(GO:0048873) |
0.2 | 1.3 | GO:1901475 | pyruvate transport(GO:0006848) pyruvate transmembrane transport(GO:1901475) |
0.2 | 2.5 | GO:0015812 | gamma-aminobutyric acid transport(GO:0015812) |
0.2 | 2.4 | GO:0030214 | hyaluronan catabolic process(GO:0030214) |
0.2 | 0.8 | GO:1903527 | positive regulation of membrane tubulation(GO:1903527) |
0.2 | 1.4 | GO:0071600 | otic vesicle morphogenesis(GO:0071600) |
0.2 | 2.2 | GO:0060453 | regulation of gastric acid secretion(GO:0060453) |
0.2 | 0.9 | GO:0002175 | protein localization to paranode region of axon(GO:0002175) |
0.2 | 6.7 | GO:0032212 | positive regulation of telomere maintenance via telomerase(GO:0032212) |
0.1 | 4.0 | GO:0060325 | face morphogenesis(GO:0060325) |
0.1 | 1.5 | GO:0006335 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
0.1 | 1.5 | GO:0032264 | IMP salvage(GO:0032264) |
0.1 | 2.9 | GO:0035082 | axoneme assembly(GO:0035082) |
0.1 | 1.3 | GO:0006682 | galactosylceramide biosynthetic process(GO:0006682) galactolipid biosynthetic process(GO:0019375) |
0.1 | 2.2 | GO:0030205 | dermatan sulfate metabolic process(GO:0030205) |
0.1 | 1.4 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.1 | 0.7 | GO:0001555 | oocyte growth(GO:0001555) |
0.1 | 0.6 | GO:0006542 | glutamine biosynthetic process(GO:0006542) |
0.1 | 1.1 | GO:0035871 | protein K11-linked deubiquitination(GO:0035871) |
0.1 | 1.1 | GO:0070257 | positive regulation of mucus secretion(GO:0070257) |
0.1 | 5.2 | GO:0051693 | actin filament capping(GO:0051693) |
0.1 | 1.8 | GO:0034505 | tooth mineralization(GO:0034505) |
0.1 | 5.4 | GO:0007271 | synaptic transmission, cholinergic(GO:0007271) |
0.1 | 1.9 | GO:0019934 | cGMP-mediated signaling(GO:0019934) |
0.1 | 2.4 | GO:0016973 | poly(A)+ mRNA export from nucleus(GO:0016973) |
0.1 | 15.9 | GO:0006903 | vesicle targeting(GO:0006903) |
0.1 | 4.9 | GO:0070206 | protein trimerization(GO:0070206) |
0.1 | 1.8 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.1 | 3.6 | GO:0034605 | cellular response to heat(GO:0034605) |
0.1 | 1.2 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
0.1 | 0.5 | GO:0098532 | histone H3-K27 trimethylation(GO:0098532) |
0.1 | 0.7 | GO:1903845 | negative regulation of transforming growth factor beta receptor signaling pathway(GO:0030512) negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway(GO:0090101) negative regulation of cellular response to transforming growth factor beta stimulus(GO:1903845) |
0.1 | 0.5 | GO:0097210 | response to gonadotropin-releasing hormone(GO:0097210) cellular response to gonadotropin-releasing hormone(GO:0097211) |
0.1 | 3.6 | GO:0051567 | histone H3-K9 methylation(GO:0051567) |
0.1 | 0.9 | GO:0010763 | positive regulation of fibroblast migration(GO:0010763) |
0.1 | 1.2 | GO:0006553 | lysine metabolic process(GO:0006553) lysine catabolic process(GO:0006554) |
0.1 | 3.7 | GO:0016266 | O-glycan processing(GO:0016266) |
0.1 | 1.7 | GO:0070193 | synaptonemal complex assembly(GO:0007130) synaptonemal complex organization(GO:0070193) |
0.1 | 3.3 | GO:0050829 | defense response to Gram-negative bacterium(GO:0050829) |
0.1 | 1.2 | GO:1904903 | ESCRT complex disassembly(GO:1904896) ESCRT III complex disassembly(GO:1904903) |
0.1 | 2.2 | GO:0008038 | neuron recognition(GO:0008038) |
0.1 | 1.1 | GO:0008627 | intrinsic apoptotic signaling pathway in response to osmotic stress(GO:0008627) |
0.1 | 2.0 | GO:0071420 | cellular response to histamine(GO:0071420) |
0.1 | 0.7 | GO:0033600 | negative regulation of mammary gland epithelial cell proliferation(GO:0033600) |
0.1 | 1.3 | GO:0035020 | regulation of Rac protein signal transduction(GO:0035020) |
0.1 | 0.8 | GO:0071803 | positive regulation of podosome assembly(GO:0071803) |
0.1 | 1.6 | GO:0060397 | JAK-STAT cascade involved in growth hormone signaling pathway(GO:0060397) |
0.1 | 0.5 | GO:0000712 | resolution of meiotic recombination intermediates(GO:0000712) |
0.1 | 3.2 | GO:0018146 | keratan sulfate biosynthetic process(GO:0018146) |
0.1 | 5.2 | GO:0046847 | filopodium assembly(GO:0046847) |
0.1 | 1.1 | GO:1902222 | L-phenylalanine metabolic process(GO:0006558) L-phenylalanine catabolic process(GO:0006559) erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process(GO:1902221) erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process(GO:1902222) |
0.1 | 2.9 | GO:0050870 | positive regulation of T cell activation(GO:0050870) |
0.1 | 8.5 | GO:1902476 | chloride transmembrane transport(GO:1902476) |
0.1 | 2.0 | GO:0007030 | Golgi organization(GO:0007030) |
0.1 | 0.8 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
0.1 | 3.7 | GO:0032760 | positive regulation of tumor necrosis factor production(GO:0032760) |
0.1 | 2.3 | GO:0072661 | protein targeting to plasma membrane(GO:0072661) |
0.1 | 0.2 | GO:0036353 | histone H2A-K119 monoubiquitination(GO:0036353) |
0.1 | 7.1 | GO:0032436 | positive regulation of proteasomal ubiquitin-dependent protein catabolic process(GO:0032436) |
0.1 | 1.6 | GO:0090140 | regulation of mitochondrial fission(GO:0090140) |
0.1 | 1.3 | GO:0010801 | negative regulation of peptidyl-threonine phosphorylation(GO:0010801) |
0.1 | 1.0 | GO:0007398 | ectoderm development(GO:0007398) |
0.1 | 1.6 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.1 | 1.3 | GO:0044804 | nucleophagy(GO:0044804) |
0.1 | 0.1 | GO:0046668 | regulation of retinal cell programmed cell death(GO:0046668) |
0.1 | 3.3 | GO:0006687 | glycosphingolipid metabolic process(GO:0006687) |
0.1 | 1.2 | GO:0007229 | integrin-mediated signaling pathway(GO:0007229) |
0.1 | 0.2 | GO:0090118 | receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport(GO:0090118) regulation of microglial cell activation(GO:1903978) positive regulation of lysosomal protein catabolic process(GO:1905167) |
0.1 | 0.2 | GO:0097240 | meiotic telomere tethering at nuclear periphery(GO:0044821) meiotic attachment of telomere to nuclear envelope(GO:0070197) chromosome attachment to the nuclear envelope(GO:0097240) |
0.1 | 0.5 | GO:0031848 | protection from non-homologous end joining at telomere(GO:0031848) |
0.1 | 2.5 | GO:0002250 | adaptive immune response(GO:0002250) |
0.1 | 2.5 | GO:0048247 | lymphocyte chemotaxis(GO:0048247) |
0.1 | 1.4 | GO:0006068 | ethanol catabolic process(GO:0006068) |
0.1 | 3.1 | GO:0006501 | C-terminal protein lipidation(GO:0006501) |
0.1 | 0.8 | GO:1902400 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest(GO:0006977) signal transduction involved in mitotic G1 DNA damage checkpoint(GO:0072431) intracellular signal transduction involved in G1 DNA damage checkpoint(GO:1902400) |
0.1 | 1.6 | GO:0007140 | male meiosis(GO:0007140) |
0.1 | 2.6 | GO:0006362 | transcription initiation from RNA polymerase I promoter(GO:0006361) transcription elongation from RNA polymerase I promoter(GO:0006362) termination of RNA polymerase I transcription(GO:0006363) |
0.1 | 1.1 | GO:0006475 | internal protein amino acid acetylation(GO:0006475) |
0.1 | 2.0 | GO:0090503 | RNA phosphodiester bond hydrolysis, exonucleolytic(GO:0090503) |
0.1 | 2.3 | GO:0030517 | negative regulation of axon extension(GO:0030517) |
0.1 | 4.2 | GO:0006749 | glutathione metabolic process(GO:0006749) |
0.1 | 1.3 | GO:0036152 | phosphatidylethanolamine acyl-chain remodeling(GO:0036152) |
0.1 | 0.6 | GO:0010886 | positive regulation of cholesterol storage(GO:0010886) |
0.1 | 2.2 | GO:0010107 | potassium ion import(GO:0010107) |
0.1 | 0.4 | GO:0097116 | gephyrin clustering involved in postsynaptic density assembly(GO:0097116) |
0.1 | 3.4 | GO:0050868 | negative regulation of T cell activation(GO:0050868) |
0.1 | 0.5 | GO:0097094 | craniofacial suture morphogenesis(GO:0097094) |
0.0 | 1.8 | GO:0097435 | fibril organization(GO:0097435) |
0.0 | 3.6 | GO:0045814 | negative regulation of gene expression, epigenetic(GO:0045814) |
0.0 | 0.2 | GO:0045906 | regulation of vascular smooth muscle contraction(GO:0003056) negative regulation of vasoconstriction(GO:0045906) |
0.0 | 0.1 | GO:0032430 | positive regulation of phospholipase A2 activity(GO:0032430) |
0.0 | 1.7 | GO:1904837 | beta-catenin-TCF complex assembly(GO:1904837) |
0.0 | 0.6 | GO:0034142 | toll-like receptor 4 signaling pathway(GO:0034142) |
0.0 | 0.5 | GO:0008053 | mitochondrial fusion(GO:0008053) |
0.0 | 1.6 | GO:0015701 | bicarbonate transport(GO:0015701) |
0.0 | 1.0 | GO:0043277 | apoptotic cell clearance(GO:0043277) |
0.0 | 2.5 | GO:0007409 | axonogenesis(GO:0007409) |
0.0 | 0.2 | GO:0047484 | regulation of response to osmotic stress(GO:0047484) |
0.0 | 0.9 | GO:0009954 | proximal/distal pattern formation(GO:0009954) |
0.0 | 2.3 | GO:0018022 | peptidyl-lysine methylation(GO:0018022) |
0.0 | 1.1 | GO:0046825 | regulation of protein export from nucleus(GO:0046825) |
0.0 | 3.8 | GO:0030041 | actin filament polymerization(GO:0030041) |
0.0 | 0.3 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
0.0 | 1.1 | GO:0043268 | positive regulation of potassium ion transport(GO:0043268) |
0.0 | 6.4 | GO:0007601 | visual perception(GO:0007601) |
0.0 | 0.2 | GO:0009642 | response to light intensity(GO:0009642) |
0.0 | 3.7 | GO:0031424 | keratinization(GO:0031424) |
0.0 | 0.3 | GO:0016576 | histone dephosphorylation(GO:0016576) |
0.0 | 0.4 | GO:0036344 | platelet formation(GO:0030220) platelet morphogenesis(GO:0036344) |
0.0 | 0.4 | GO:0007617 | mating behavior(GO:0007617) multi-organism reproductive behavior(GO:0044705) |
0.0 | 0.4 | GO:0019388 | galactose catabolic process(GO:0019388) |
0.0 | 2.5 | GO:0006367 | transcription initiation from RNA polymerase II promoter(GO:0006367) |
0.0 | 5.4 | GO:0018105 | peptidyl-serine phosphorylation(GO:0018105) |
0.0 | 0.1 | GO:0002523 | leukocyte migration involved in inflammatory response(GO:0002523) |
0.0 | 0.6 | GO:0044849 | estrous cycle(GO:0044849) |
0.0 | 0.9 | GO:0009988 | cell-cell recognition(GO:0009988) |
0.0 | 0.6 | GO:0030199 | collagen fibril organization(GO:0030199) |
0.0 | 1.4 | GO:0002456 | T cell mediated immunity(GO:0002456) |
0.0 | 1.4 | GO:1901264 | carbohydrate derivative transport(GO:1901264) |
0.0 | 0.8 | GO:0033344 | cholesterol efflux(GO:0033344) |
0.0 | 2.4 | GO:1990830 | response to leukemia inhibitory factor(GO:1990823) cellular response to leukemia inhibitory factor(GO:1990830) |
0.0 | 0.8 | GO:0007595 | lactation(GO:0007595) |
0.0 | 0.1 | GO:0060462 | lung lobe development(GO:0060462) lung lobe morphogenesis(GO:0060463) |
0.0 | 0.9 | GO:1904893 | negative regulation of JAK-STAT cascade(GO:0046426) negative regulation of STAT cascade(GO:1904893) |
0.0 | 0.7 | GO:0006611 | protein export from nucleus(GO:0006611) |
0.0 | 0.0 | GO:0032289 | central nervous system myelin formation(GO:0032289) |
0.0 | 0.3 | GO:0006020 | inositol metabolic process(GO:0006020) |
0.0 | 0.5 | GO:0006825 | copper ion transport(GO:0006825) |
0.0 | 0.4 | GO:0007274 | neuromuscular synaptic transmission(GO:0007274) |
0.0 | 0.3 | GO:0001764 | neuron migration(GO:0001764) |
0.0 | 0.1 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
0.0 | 0.0 | GO:0035989 | tendon development(GO:0035989) tendon cell differentiation(GO:0035990) tendon formation(GO:0035992) |
0.0 | 0.6 | GO:0005977 | glycogen metabolic process(GO:0005977) cellular glucan metabolic process(GO:0006073) energy reserve metabolic process(GO:0006112) glucan metabolic process(GO:0044042) |
0.0 | 1.0 | GO:0031497 | chromatin assembly(GO:0031497) |
0.0 | 2.1 | GO:0000910 | cytokinesis(GO:0000910) |
0.0 | 1.0 | GO:0035914 | skeletal muscle cell differentiation(GO:0035914) |
0.0 | 4.1 | GO:0010951 | negative regulation of endopeptidase activity(GO:0010951) |
0.0 | 7.1 | GO:0048232 | spermatogenesis(GO:0007283) male gamete generation(GO:0048232) |
0.0 | 1.3 | GO:0043433 | negative regulation of sequence-specific DNA binding transcription factor activity(GO:0043433) |
0.0 | 1.2 | GO:0036498 | IRE1-mediated unfolded protein response(GO:0036498) |
0.0 | 0.3 | GO:0042149 | cellular response to glucose starvation(GO:0042149) |
0.0 | 4.0 | GO:0006413 | translational initiation(GO:0006413) |
0.0 | 0.2 | GO:0044458 | motile cilium assembly(GO:0044458) |
0.0 | 0.2 | GO:0008380 | RNA splicing(GO:0008380) |
0.0 | 1.0 | GO:0007265 | Ras protein signal transduction(GO:0007265) |
0.0 | 0.4 | GO:0031214 | biomineral tissue development(GO:0031214) |
0.0 | 0.6 | GO:0035418 | protein localization to synapse(GO:0035418) |
0.0 | 0.0 | GO:0048840 | otolith development(GO:0048840) |
0.0 | 0.1 | GO:0060394 | negative regulation of SMAD protein complex assembly(GO:0010991) negative regulation of pathway-restricted SMAD protein phosphorylation(GO:0060394) |
0.0 | 0.1 | GO:0050974 | detection of mechanical stimulus involved in sensory perception(GO:0050974) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
5.2 | 10.5 | GO:0020003 | symbiont-containing vacuole(GO:0020003) symbiont-containing vacuole membrane(GO:0020005) |
4.7 | 14.1 | GO:0097679 | other organism cytoplasm(GO:0097679) |
1.9 | 39.1 | GO:0042613 | MHC class II protein complex(GO:0042613) |
1.4 | 4.1 | GO:0035354 | Toll-like receptor 1-Toll-like receptor 2 protein complex(GO:0035354) |
1.2 | 3.6 | GO:0044609 | DBIRD complex(GO:0044609) |
1.2 | 3.5 | GO:0030895 | apolipoprotein B mRNA editing enzyme complex(GO:0030895) |
1.2 | 3.5 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
1.1 | 13.2 | GO:0098643 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
1.0 | 2.9 | GO:0031251 | PAN complex(GO:0031251) |
1.0 | 6.8 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
1.0 | 1.9 | GO:0030430 | host cell cytoplasm(GO:0030430) host cell cytoplasm part(GO:0033655) |
0.9 | 2.7 | GO:0033011 | perinuclear theca(GO:0033011) cytoskeletal calyx(GO:0033150) |
0.9 | 4.5 | GO:0031205 | endoplasmic reticulum Sec complex(GO:0031205) |
0.9 | 4.5 | GO:1902937 | inward rectifier potassium channel complex(GO:1902937) |
0.7 | 5.2 | GO:0032437 | cuticular plate(GO:0032437) |
0.7 | 2.2 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.7 | 11.8 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.7 | 2.0 | GO:1990812 | growth cone filopodium(GO:1990812) |
0.5 | 4.3 | GO:0036157 | outer dynein arm(GO:0036157) |
0.5 | 2.4 | GO:0042272 | nuclear RNA export factor complex(GO:0042272) |
0.5 | 1.9 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
0.4 | 2.2 | GO:0005579 | membrane attack complex(GO:0005579) |
0.4 | 37.8 | GO:1904724 | tertiary granule lumen(GO:1904724) |
0.4 | 9.6 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
0.4 | 2.8 | GO:0044294 | dendritic growth cone(GO:0044294) |
0.4 | 3.9 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.4 | 20.8 | GO:0001533 | cornified envelope(GO:0001533) |
0.4 | 5.4 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
0.4 | 1.5 | GO:0033186 | CAF-1 complex(GO:0033186) |
0.4 | 2.6 | GO:0000120 | RNA polymerase I transcription factor complex(GO:0000120) |
0.4 | 1.8 | GO:0005602 | complement component C1 complex(GO:0005602) |
0.3 | 1.7 | GO:0000801 | central element(GO:0000801) |
0.3 | 7.3 | GO:0043205 | microfibril(GO:0001527) fibril(GO:0043205) |
0.3 | 9.1 | GO:0034451 | centriolar satellite(GO:0034451) |
0.3 | 7.5 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
0.3 | 2.1 | GO:0071203 | WASH complex(GO:0071203) |
0.3 | 63.6 | GO:0072562 | blood microparticle(GO:0072562) |
0.3 | 2.5 | GO:0016013 | syntrophin complex(GO:0016013) |
0.3 | 3.3 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
0.3 | 1.6 | GO:0070369 | beta-catenin-TCF7L2 complex(GO:0070369) catenin-TCF7L2 complex(GO:0071664) |
0.2 | 5.3 | GO:0032982 | myosin filament(GO:0032982) |
0.2 | 0.8 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
0.2 | 2.3 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.2 | 1.1 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.2 | 12.4 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.2 | 4.3 | GO:0090665 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
0.2 | 3.1 | GO:0031083 | BLOC-1 complex(GO:0031083) |
0.2 | 5.8 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
0.2 | 5.0 | GO:0005720 | nuclear heterochromatin(GO:0005720) |
0.2 | 26.1 | GO:0045111 | intermediate filament cytoskeleton(GO:0045111) |
0.2 | 0.9 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.1 | 11.2 | GO:0035577 | azurophil granule membrane(GO:0035577) |
0.1 | 20.0 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.1 | 5.2 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
0.1 | 2.7 | GO:0097225 | sperm midpiece(GO:0097225) |
0.1 | 10.6 | GO:0034707 | chloride channel complex(GO:0034707) |
0.1 | 1.4 | GO:0030015 | CCR4-NOT core complex(GO:0030015) |
0.1 | 2.0 | GO:0033270 | paranode region of axon(GO:0033270) |
0.1 | 1.6 | GO:0005642 | annulate lamellae(GO:0005642) |
0.1 | 2.0 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
0.1 | 1.6 | GO:0042555 | MCM complex(GO:0042555) |
0.1 | 4.1 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
0.1 | 1.2 | GO:0000788 | nuclear nucleosome(GO:0000788) |
0.1 | 0.9 | GO:0000322 | storage vacuole(GO:0000322) |
0.1 | 8.9 | GO:0005811 | lipid particle(GO:0005811) |
0.1 | 1.2 | GO:0000815 | ESCRT III complex(GO:0000815) |
0.1 | 1.9 | GO:0005922 | connexon complex(GO:0005922) |
0.1 | 0.6 | GO:0072558 | NLRP1 inflammasome complex(GO:0072558) |
0.1 | 5.5 | GO:0015030 | Cajal body(GO:0015030) |
0.1 | 1.3 | GO:0070419 | nonhomologous end joining complex(GO:0070419) |
0.1 | 2.3 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.1 | 118.7 | GO:0005615 | extracellular space(GO:0005615) |
0.1 | 2.9 | GO:0005796 | Golgi lumen(GO:0005796) |
0.1 | 0.7 | GO:0000800 | lateral element(GO:0000800) |
0.1 | 0.8 | GO:0033162 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
0.1 | 1.2 | GO:0031201 | SNARE complex(GO:0031201) |
0.1 | 6.4 | GO:0016605 | PML body(GO:0016605) |
0.1 | 1.6 | GO:0031904 | endosome lumen(GO:0031904) |
0.0 | 0.9 | GO:0030673 | axolemma(GO:0030673) |
0.0 | 2.8 | GO:0005604 | basement membrane(GO:0005604) |
0.0 | 1.6 | GO:0000786 | nucleosome(GO:0000786) |
0.0 | 0.8 | GO:0097381 | photoreceptor disc membrane(GO:0097381) |
0.0 | 2.2 | GO:0031519 | PcG protein complex(GO:0031519) |
0.0 | 1.5 | GO:0016235 | aggresome(GO:0016235) |
0.0 | 3.2 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
0.0 | 1.3 | GO:0001917 | photoreceptor inner segment(GO:0001917) |
0.0 | 0.3 | GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex(GO:0031464) |
0.0 | 2.9 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.0 | 3.7 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) potassium channel complex(GO:0034705) |
0.0 | 0.8 | GO:0005581 | collagen trimer(GO:0005581) |
0.0 | 4.8 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.0 | 0.4 | GO:0030130 | clathrin coat of trans-Golgi network vesicle(GO:0030130) |
0.0 | 1.1 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
0.0 | 0.9 | GO:0030686 | 90S preribosome(GO:0030686) |
0.0 | 0.3 | GO:0044666 | MLL3/4 complex(GO:0044666) |
0.0 | 1.6 | GO:0030315 | T-tubule(GO:0030315) |
0.0 | 0.4 | GO:0042383 | sarcolemma(GO:0042383) |
0.0 | 0.9 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
0.0 | 1.0 | GO:0036064 | ciliary basal body(GO:0036064) |
0.0 | 0.5 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
0.0 | 1.9 | GO:0016591 | DNA-directed RNA polymerase II, holoenzyme(GO:0016591) |
0.0 | 0.4 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.0 | 2.2 | GO:0055037 | recycling endosome(GO:0055037) |
0.0 | 0.7 | GO:0005902 | microvillus(GO:0005902) |
0.0 | 0.2 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.0 | 6.3 | GO:0016604 | nuclear body(GO:0016604) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
5.5 | 16.5 | GO:0035662 | Toll-like receptor 4 binding(GO:0035662) |
3.6 | 10.9 | GO:0035379 | carbon dioxide transmembrane transporter activity(GO:0035379) |
2.3 | 11.3 | GO:0017159 | pantetheine hydrolase activity(GO:0017159) |
2.1 | 10.3 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
1.9 | 7.6 | GO:0035473 | lipase binding(GO:0035473) |
1.5 | 4.5 | GO:0005260 | channel-conductance-controlling ATPase activity(GO:0005260) |
1.5 | 5.8 | GO:0030107 | HLA-A specific inhibitory MHC class I receptor activity(GO:0030107) |
1.4 | 4.1 | GO:0033188 | sphingomyelin synthase activity(GO:0033188) ceramide cholinephosphotransferase activity(GO:0047493) |
1.4 | 4.1 | GO:0034041 | sterol-transporting ATPase activity(GO:0034041) |
1.4 | 4.1 | GO:0046848 | hydroxyapatite binding(GO:0046848) |
1.3 | 3.9 | GO:0061663 | NEDD8 ligase activity(GO:0061663) |
1.3 | 6.4 | GO:0061665 | SUMO ligase activity(GO:0061665) |
1.2 | 7.4 | GO:0009378 | four-way junction helicase activity(GO:0009378) |
1.2 | 9.6 | GO:0034235 | GPI anchor binding(GO:0034235) |
1.2 | 3.6 | GO:0004813 | alanine-tRNA ligase activity(GO:0004813) |
1.1 | 3.4 | GO:0001181 | transcription factor activity, core RNA polymerase I binding(GO:0001181) |
1.1 | 3.2 | GO:0004917 | interleukin-7 receptor activity(GO:0004917) |
1.1 | 2.1 | GO:0035663 | Toll-like receptor 2 binding(GO:0035663) |
1.0 | 5.2 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
1.0 | 7.1 | GO:0015562 | efflux transmembrane transporter activity(GO:0015562) |
1.0 | 5.9 | GO:0004522 | ribonuclease A activity(GO:0004522) |
1.0 | 30.6 | GO:0023026 | MHC class II protein complex binding(GO:0023026) |
0.8 | 2.5 | GO:0070052 | collagen V binding(GO:0070052) |
0.8 | 2.5 | GO:0003883 | CTP synthase activity(GO:0003883) |
0.8 | 2.4 | GO:0050528 | acyloxyacyl hydrolase activity(GO:0050528) |
0.7 | 147.1 | GO:0003823 | antigen binding(GO:0003823) |
0.7 | 2.9 | GO:0035939 | microsatellite binding(GO:0035939) |
0.7 | 7.1 | GO:0019826 | oxygen sensor activity(GO:0019826) |
0.7 | 2.7 | GO:0004657 | proline dehydrogenase activity(GO:0004657) |
0.7 | 6.7 | GO:0003720 | telomerase activity(GO:0003720) RNA-directed DNA polymerase activity(GO:0003964) |
0.7 | 2.0 | GO:0071723 | lipopeptide binding(GO:0071723) |
0.6 | 1.9 | GO:0004833 | tryptophan 2,3-dioxygenase activity(GO:0004833) |
0.6 | 1.9 | GO:0051880 | G-quadruplex DNA binding(GO:0051880) |
0.6 | 5.0 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
0.6 | 1.7 | GO:0032089 | NACHT domain binding(GO:0032089) |
0.6 | 13.9 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.6 | 2.3 | GO:0022850 | serotonin-gated cation channel activity(GO:0022850) |
0.6 | 2.8 | GO:0097108 | hedgehog family protein binding(GO:0097108) |
0.6 | 7.3 | GO:0048019 | receptor antagonist activity(GO:0048019) |
0.6 | 2.2 | GO:0022858 | L-alanine transmembrane transporter activity(GO:0015180) alanine transmembrane transporter activity(GO:0022858) |
0.6 | 2.8 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
0.5 | 1.6 | GO:0005148 | prolactin receptor binding(GO:0005148) |
0.5 | 2.1 | GO:0000702 | oxidized base lesion DNA N-glycosylase activity(GO:0000702) |
0.5 | 3.5 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.5 | 5.7 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.5 | 2.3 | GO:0004771 | sterol esterase activity(GO:0004771) |
0.5 | 4.1 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
0.4 | 1.8 | GO:0004948 | calcitonin receptor activity(GO:0004948) |
0.4 | 1.3 | GO:0047275 | glucosaminylgalactosylglucosylceramide beta-galactosyltransferase activity(GO:0047275) |
0.4 | 3.4 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.4 | 2.5 | GO:0015185 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) gamma-aminobutyric acid transmembrane transporter activity(GO:0015185) |
0.4 | 5.2 | GO:0031432 | titin binding(GO:0031432) |
0.4 | 2.6 | GO:0050294 | steroid sulfotransferase activity(GO:0050294) |
0.4 | 7.5 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
0.4 | 4.9 | GO:0004065 | arylsulfatase activity(GO:0004065) |
0.3 | 1.3 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
0.3 | 0.7 | GO:0030109 | HLA-B specific inhibitory MHC class I receptor activity(GO:0030109) |
0.3 | 4.3 | GO:0019957 | C-C chemokine binding(GO:0019957) |
0.3 | 4.6 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
0.3 | 3.3 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
0.3 | 2.3 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.3 | 2.3 | GO:0004022 | alcohol dehydrogenase (NAD) activity(GO:0004022) |
0.3 | 1.6 | GO:0004692 | cGMP-dependent protein kinase activity(GO:0004692) |
0.3 | 1.3 | GO:0005477 | pyruvate secondary active transmembrane transporter activity(GO:0005477) |
0.3 | 0.9 | GO:0030197 | extracellular matrix constituent, lubricant activity(GO:0030197) |
0.3 | 2.8 | GO:0001162 | RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding(GO:0001162) |
0.3 | 1.2 | GO:0047708 | biotinidase activity(GO:0047708) |
0.3 | 1.2 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.3 | 5.8 | GO:0033130 | acetylcholine receptor binding(GO:0033130) |
0.3 | 3.9 | GO:0008517 | folic acid transporter activity(GO:0008517) |
0.3 | 1.2 | GO:0016639 | oxidoreductase activity, acting on the CH-NH2 group of donors, NAD or NADP as acceptor(GO:0016639) |
0.3 | 7.3 | GO:0038187 | signaling pattern recognition receptor activity(GO:0008329) pattern recognition receptor activity(GO:0038187) |
0.3 | 4.3 | GO:0015643 | toxic substance binding(GO:0015643) |
0.3 | 5.1 | GO:0070330 | aromatase activity(GO:0070330) |
0.3 | 3.1 | GO:0004568 | chitinase activity(GO:0004568) chitin binding(GO:0008061) |
0.3 | 1.1 | GO:0004505 | phenylalanine 4-monooxygenase activity(GO:0004505) |
0.3 | 1.4 | GO:0030021 | extracellular matrix structural constituent conferring compression resistance(GO:0030021) structural constituent of tooth enamel(GO:0030345) |
0.3 | 8.2 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.3 | 1.1 | GO:0004165 | dodecenoyl-CoA delta-isomerase activity(GO:0004165) |
0.3 | 28.5 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.2 | 4.0 | GO:0019864 | IgG binding(GO:0019864) |
0.2 | 2.5 | GO:0008499 | UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity(GO:0008499) |
0.2 | 2.2 | GO:0043225 | anion transmembrane-transporting ATPase activity(GO:0043225) |
0.2 | 2.6 | GO:0022820 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
0.2 | 4.3 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
0.2 | 1.4 | GO:0001161 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) intronic transcription regulatory region DNA binding(GO:0044213) |
0.2 | 3.1 | GO:0052629 | phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity(GO:0052629) |
0.2 | 2.5 | GO:0001135 | transcription factor activity, RNA polymerase II transcription factor recruiting(GO:0001135) |
0.2 | 0.5 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.2 | 19.0 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.2 | 7.5 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) |
0.2 | 0.9 | GO:0005502 | 11-cis retinal binding(GO:0005502) |
0.2 | 4.3 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
0.2 | 3.6 | GO:0003680 | AT DNA binding(GO:0003680) |
0.2 | 2.9 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
0.2 | 0.6 | GO:0017129 | triglyceride binding(GO:0017129) |
0.2 | 6.2 | GO:0046965 | retinoid X receptor binding(GO:0046965) |
0.2 | 14.9 | GO:0004712 | protein serine/threonine/tyrosine kinase activity(GO:0004712) |
0.2 | 0.6 | GO:0005137 | interleukin-5 receptor binding(GO:0005137) |
0.2 | 2.2 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.2 | 1.5 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
0.2 | 3.4 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.2 | 3.6 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.2 | 1.8 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.2 | 3.1 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.2 | 3.1 | GO:0005522 | profilin binding(GO:0005522) |
0.2 | 2.2 | GO:0001011 | transcription factor activity, sequence-specific DNA binding, RNA polymerase recruiting(GO:0001011) transcription factor activity, TFIIB-class binding(GO:0001087) |
0.2 | 1.8 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
0.2 | 1.3 | GO:0047144 | 2-acylglycerol-3-phosphate O-acyltransferase activity(GO:0047144) |
0.2 | 1.5 | GO:0003876 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
0.2 | 2.4 | GO:0009931 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) |
0.2 | 1.1 | GO:0001102 | RNA polymerase II activating transcription factor binding(GO:0001102) |
0.1 | 7.9 | GO:0001047 | core promoter binding(GO:0001047) |
0.1 | 18.1 | GO:0020037 | heme binding(GO:0020037) |
0.1 | 4.5 | GO:0001671 | ATPase activator activity(GO:0001671) |
0.1 | 2.2 | GO:0005351 | sugar:proton symporter activity(GO:0005351) cation:sugar symporter activity(GO:0005402) |
0.1 | 1.2 | GO:1904315 | neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential(GO:0099529) transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1904315) |
0.1 | 2.6 | GO:0001164 | RNA polymerase I regulatory region DNA binding(GO:0001013) RNA polymerase I regulatory region sequence-specific DNA binding(GO:0001163) RNA polymerase I CORE element sequence-specific DNA binding(GO:0001164) |
0.1 | 1.4 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
0.1 | 0.6 | GO:0016880 | glutamate-ammonia ligase activity(GO:0004356) ammonia ligase activity(GO:0016211) acid-ammonia (or amide) ligase activity(GO:0016880) |
0.1 | 1.5 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.1 | 13.0 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.1 | 0.9 | GO:0052739 | phosphatidylserine 1-acylhydrolase activity(GO:0052739) |
0.1 | 3.8 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.1 | 2.2 | GO:0050786 | RAGE receptor binding(GO:0050786) |
0.1 | 0.9 | GO:0015501 | glutamate:sodium symporter activity(GO:0015501) |
0.1 | 5.5 | GO:0030544 | Hsp70 protein binding(GO:0030544) |
0.1 | 3.2 | GO:0016769 | transferase activity, transferring nitrogenous groups(GO:0016769) |
0.1 | 1.5 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.1 | 1.9 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.1 | 7.7 | GO:0050840 | extracellular matrix binding(GO:0050840) |
0.1 | 1.6 | GO:0048156 | tau protein binding(GO:0048156) |
0.1 | 2.2 | GO:0008510 | sodium:bicarbonate symporter activity(GO:0008510) |
0.1 | 2.0 | GO:0008494 | translation activator activity(GO:0008494) |
0.1 | 1.1 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
0.1 | 11.2 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.1 | 1.3 | GO:0000014 | single-stranded DNA endodeoxyribonuclease activity(GO:0000014) |
0.1 | 8.4 | GO:0005254 | chloride channel activity(GO:0005254) |
0.1 | 1.0 | GO:0016918 | retinal binding(GO:0016918) |
0.1 | 4.2 | GO:0004364 | glutathione transferase activity(GO:0004364) |
0.1 | 1.6 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.1 | 1.6 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.1 | 1.2 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.1 | 3.9 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.1 | 4.8 | GO:0043022 | ribosome binding(GO:0043022) |
0.1 | 5.5 | GO:0097110 | scaffold protein binding(GO:0097110) |
0.1 | 1.6 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.1 | 3.3 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.1 | 1.8 | GO:0043548 | phosphatidylinositol 3-kinase binding(GO:0043548) |
0.1 | 2.2 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.1 | 3.7 | GO:0004402 | histone acetyltransferase activity(GO:0004402) peptide-lysine-N-acetyltransferase activity(GO:0061733) |
0.1 | 1.8 | GO:0005355 | glucose transmembrane transporter activity(GO:0005355) |
0.1 | 1.6 | GO:0005112 | Notch binding(GO:0005112) |
0.1 | 4.1 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.1 | 0.4 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
0.1 | 2.1 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.1 | 1.1 | GO:0008080 | N-acetyltransferase activity(GO:0008080) |
0.1 | 0.4 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
0.1 | 0.6 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
0.1 | 0.3 | GO:0033857 | diphosphoinositol-pentakisphosphate kinase activity(GO:0033857) |
0.1 | 3.3 | GO:0051539 | 4 iron, 4 sulfur cluster binding(GO:0051539) |
0.1 | 2.0 | GO:0005044 | scavenger receptor activity(GO:0005044) |
0.1 | 2.5 | GO:0048020 | CCR chemokine receptor binding(GO:0048020) |
0.1 | 0.2 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
0.1 | 11.3 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.1 | 0.5 | GO:0004322 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
0.1 | 1.0 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
0.1 | 2.5 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
0.1 | 2.6 | GO:0043621 | protein self-association(GO:0043621) |
0.1 | 0.3 | GO:0004882 | androgen receptor activity(GO:0004882) |
0.1 | 1.5 | GO:0003785 | actin monomer binding(GO:0003785) |
0.1 | 0.8 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
0.0 | 6.9 | GO:0001078 | transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001078) |
0.0 | 0.1 | GO:0031711 | angiotensin type I receptor activity(GO:0001596) bradykinin receptor binding(GO:0031711) |
0.0 | 0.6 | GO:0005537 | mannose binding(GO:0005537) |
0.0 | 3.7 | GO:0000980 | RNA polymerase II distal enhancer sequence-specific DNA binding(GO:0000980) |
0.0 | 6.4 | GO:0001046 | core promoter sequence-specific DNA binding(GO:0001046) |
0.0 | 0.7 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
0.0 | 0.9 | GO:0016702 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen(GO:0016702) |
0.0 | 0.4 | GO:0004977 | melanocortin receptor activity(GO:0004977) |
0.0 | 0.9 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
0.0 | 3.1 | GO:0001227 | transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001227) |
0.0 | 1.2 | GO:0001105 | RNA polymerase II transcription coactivator activity(GO:0001105) |
0.0 | 0.3 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
0.0 | 0.2 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
0.0 | 0.5 | GO:0051400 | BH domain binding(GO:0051400) |
0.0 | 0.7 | GO:0030971 | receptor tyrosine kinase binding(GO:0030971) |
0.0 | 1.4 | GO:0005507 | copper ion binding(GO:0005507) |
0.0 | 0.8 | GO:0019894 | kinesin binding(GO:0019894) |
0.0 | 0.6 | GO:0031593 | polyubiquitin binding(GO:0031593) |
0.0 | 5.4 | GO:0030246 | carbohydrate binding(GO:0030246) |
0.0 | 0.1 | GO:0008381 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
0.0 | 0.4 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
0.0 | 0.4 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.0 | 0.3 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
0.0 | 1.6 | GO:0051082 | unfolded protein binding(GO:0051082) |
0.0 | 0.1 | GO:0070492 | oligosaccharide binding(GO:0070492) |
0.0 | 0.1 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
0.0 | 0.2 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.0 | 1.5 | GO:0005262 | calcium channel activity(GO:0005262) |
0.0 | 0.9 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
0.0 | 0.3 | GO:1905030 | voltage-gated sodium channel activity(GO:0005248) voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1905030) |
0.0 | 0.2 | GO:0015144 | carbohydrate transmembrane transporter activity(GO:0015144) carbohydrate transporter activity(GO:1901476) |
0.0 | 0.9 | GO:0005179 | hormone activity(GO:0005179) |
0.0 | 0.5 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.0 | 0.8 | GO:0036459 | thiol-dependent ubiquitinyl hydrolase activity(GO:0036459) ubiquitinyl hydrolase activity(GO:0101005) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.0 | 25.9 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.7 | 10.3 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
0.6 | 20.5 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.4 | 18.3 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.3 | 14.4 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.3 | 3.6 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.3 | 5.8 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.2 | 3.3 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.2 | 32.8 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.1 | 6.3 | PID BARD1 PATHWAY | BARD1 signaling events |
0.1 | 4.3 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.1 | 28.4 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.1 | 31.5 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.1 | 7.1 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.1 | 3.4 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
0.1 | 4.5 | PID RAS PATHWAY | Regulation of Ras family activation |
0.1 | 8.9 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.1 | 2.7 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.1 | 1.1 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
0.1 | 3.9 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.1 | 4.5 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.1 | 2.5 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.1 | 2.5 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.1 | 4.6 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.1 | 3.4 | PID MTOR 4PATHWAY | mTOR signaling pathway |
0.1 | 0.6 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.1 | 3.7 | PID FGF PATHWAY | FGF signaling pathway |
0.1 | 4.2 | PID AURORA B PATHWAY | Aurora B signaling |
0.1 | 1.6 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.1 | 4.1 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.1 | 4.3 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.1 | 1.3 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.1 | 0.7 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.0 | 0.8 | ST GAQ PATHWAY | G alpha q Pathway |
0.0 | 2.5 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
0.0 | 2.1 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.0 | 15.1 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.0 | 1.6 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.0 | 0.8 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.0 | 1.2 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.0 | 1.6 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.0 | 0.4 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.0 | 0.5 | PID BCR 5PATHWAY | BCR signaling pathway |
0.0 | 0.8 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.0 | 1.2 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
0.0 | 0.3 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
0.0 | 0.7 | PID LKB1 PATHWAY | LKB1 signaling events |
0.0 | 0.7 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.0 | 1.0 | PID E2F PATHWAY | E2F transcription factor network |
0.0 | 0.3 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.6 | 37.0 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
0.8 | 14.3 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
0.7 | 13.0 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.7 | 3.4 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
0.6 | 8.2 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.5 | 2.1 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.5 | 3.1 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.5 | 4.3 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.5 | 17.9 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
0.5 | 9.1 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
0.4 | 4.9 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
0.4 | 4.0 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
0.3 | 1.6 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.3 | 3.9 | REACTOME AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL | Genes involved in AKT phosphorylates targets in the cytosol |
0.3 | 7.0 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
0.2 | 4.4 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
0.2 | 13.4 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
0.2 | 4.3 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
0.2 | 4.1 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.2 | 6.4 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.2 | 1.8 | REACTOME OPSINS | Genes involved in Opsins |
0.2 | 3.6 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
0.2 | 1.8 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
0.2 | 8.7 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.2 | 3.2 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.1 | 2.4 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.1 | 4.5 | REACTOME REGULATION OF IFNA SIGNALING | Genes involved in Regulation of IFNA signaling |
0.1 | 5.9 | REACTOME RNA POL I TRANSCRIPTION INITIATION | Genes involved in RNA Polymerase I Transcription Initiation |
0.1 | 2.3 | REACTOME PRESYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Presynaptic nicotinic acetylcholine receptors |
0.1 | 3.1 | REACTOME ACYL CHAIN REMODELLING OF PE | Genes involved in Acyl chain remodelling of PE |
0.1 | 2.3 | REACTOME SIGNALING BY FGFR IN DISEASE | Genes involved in Signaling by FGFR in disease |
0.1 | 5.0 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.1 | 4.2 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.1 | 2.1 | REACTOME BASE FREE SUGAR PHOSPHATE REMOVAL VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Base-free sugar-phosphate removal via the single-nucleotide replacement pathway |
0.1 | 13.4 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.1 | 7.8 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.1 | 1.6 | REACTOME REVERSIBLE HYDRATION OF CARBON DIOXIDE | Genes involved in Reversible Hydration of Carbon Dioxide |
0.1 | 0.8 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.1 | 1.9 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.1 | 2.5 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.1 | 3.4 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.1 | 9.1 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.1 | 2.2 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.1 | 8.6 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.1 | 1.2 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
0.1 | 2.6 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.1 | 27.5 | REACTOME GENERIC TRANSCRIPTION PATHWAY | Genes involved in Generic Transcription Pathway |
0.1 | 1.4 | REACTOME FGFR2C LIGAND BINDING AND ACTIVATION | Genes involved in FGFR2c ligand binding and activation |
0.1 | 1.6 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
0.1 | 7.1 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.1 | 1.0 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.1 | 3.0 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
0.1 | 9.1 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
0.1 | 1.0 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.1 | 1.0 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
0.1 | 2.8 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.1 | 0.8 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.1 | 1.5 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.1 | 3.1 | REACTOME APOPTOTIC CLEAVAGE OF CELLULAR PROTEINS | Genes involved in Apoptotic cleavage of cellular proteins |
0.1 | 2.3 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.0 | 3.0 | REACTOME PHASE1 FUNCTIONALIZATION OF COMPOUNDS | Genes involved in Phase 1 - Functionalization of compounds |
0.0 | 1.7 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
0.0 | 1.5 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.0 | 0.7 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.0 | 0.6 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
0.0 | 0.1 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
0.0 | 0.2 | REACTOME SIGNALING BY SCF KIT | Genes involved in Signaling by SCF-KIT |
0.0 | 0.9 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.0 | 0.4 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
0.0 | 0.5 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.0 | 0.4 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.0 | 1.3 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
0.0 | 0.9 | REACTOME RNA POL II TRANSCRIPTION PRE INITIATION AND PROMOTER OPENING | Genes involved in RNA Polymerase II Transcription Pre-Initiation And Promoter Opening |
0.0 | 2.6 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.0 | 2.7 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.0 | 0.5 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
0.0 | 0.9 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.0 | 0.3 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.0 | 0.5 | REACTOME MRNA 3 END PROCESSING | Genes involved in mRNA 3'-end processing |